Since silencing KPNA2 significantly impeded the in vivo tumor growth but failed to impair the vitality and migration ability of PDAC cells in vitro, we guessed whether upregulated KPNA2 leads to tumor progression via contributing to tumor immune evasion. The gene discussed is KPNA2; the disease is neoplasm.